The WSJ vote is in: BMS, Wyeth, Biogen, Roche, Genzyme most likely take-over candidates.

Which means if you want to invest in pharma . . . perhaps these companies are the ones you should buy. After all, 1744 WSJ readers have voted in the poll and the CEO's of these companies are "least likely to be last man standing."